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Abstract
The recent clinical application of perfusion technology for the machine preservation of dona-
tion after cardiac death (DCD) grafts has some advantages. Oxygenation has been pro-
posed for the preservation of DCD liver grafts. The aim of this study is to clarify whether the
use of HbV-containing preservation solution during the subnormothermic machine perfusion
(SNMP) of the liver graft improves the graft function of DCD porcine livers in an ex vivo
reperfusion model. Pig livers were excised after 60 minutes of warm ischemic time and were
preserved under one of three preservation conditions for 4 hours. The preservation condi-
tions were as follows: 4˚C cold storage (CS group; N = 5), Hypothermic machine preserva-
tion (HMP) with UW gluconate solution (HMP group; N = 5), SNMP (21˚C) with UW
gluconate solution (SNMP group; N = 5), SNMP (21˚C) with HbVs (Hb; 1.8 mg/dl) perfusate
(SNMP+HbV group; N = 5). Autologous blood perfusion was performed for 2 hours in an iso-
lated liver reperfusion model (IRM). The oxygen consumption of the SNMP and SNMP
+HbV group was higher than the HMP groups (p < 0.05). During the reperfusion, the AST
level in the SNMP+HbV group was lower than that in the CS, HMP and SNMP groups. The
changes in pH after reperfusion was significantly lower in SNMP+HbV group than CS and
HMP groups. The ultrastructural findings indicated that the mitochondria of the SNMP+HbV
group was well maintained in comparison to the CS, HMP and SNMP groups. The SNMP
+HbVs preservation solution protected against metabolic acidosis and preserved the liver
function after reperfusion injury in the DCD liver.
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Introduction
Given the critical shortage of donor liver organs, the suitability of expanded criteria donors
(ECDs) has been explored with increasing urgency. Consequently, placement on waiting lists
carries a 10%–20% mortality rate [1]. However, the use of donated after cardiac death (DCD)
liver grafts carries an increased risk of primary non-function or ischemia-reperfusion injury.
Hypothermia has been accepted widely for preserving the transplanted organ. Cold storage
(CS) has become the standard preservation technique in the clinical practice of liver transplan-
tation due to its accessibility and low cost. However, CS has been shown to deteriorate the con-
dition of DCD liver, resulting in severe reperfusion injury and graft dysfunction [2,3].
Furthermore, the cold ischemic time was shown to be a significant risk factors for ischemic-
type biliary injury [4, 5].
Guarrera et al. showed that hypothermic (8–10˚C) machine perfusion (HMP) improves the
graft function and attenuates classical biochemical markers of liver preservation injury [6].
Other studies have reported that hypothermic oxygenated MP improves the viability and func-
tional integrity of the liver graft, despite the lack of an oxygen carrier in the preservation per-
fusate [7, 8]. Dutkowski et al. reported that the application of hypothermic oxygenated
perfusion appears to be well-tolerated, easy to use, and protective against early and later inju-
ries [9]. These results indicate the importance of oxygenation during HMP. Various preserva-
tion temperatures except hypothermia during MP have been investigated in preclinical and
clinical settings over the last 10 years to improve the outcomes and graft quality of DCD liver
transplantation. However, normothermic MP (NMP; 37˚C) has shown some advantages over
HMP. Fondevila et al. reported that NMP further improves the function of DCD livers that
were preserved for 90 min. after cardiac death [10]. However, NMP requires an oxygen carrier
because the liver grafts need full metabolic support [11,12]. Alternatively, oxygenated subnor-
mothermic MP (SNMP, 21˚C) has been shown to reduce portal venous resistance and increase
bile production, resulting in an increased hepatic functional capacity compared to HMP [13].
Furthermore, the oxygen requirements during SNMP are relatively low due to the reduced
metabolic activity of the liver and increased oxygen consumption [14,15]. Many studies have
shown that an oxygen carrier is needed under NMP, but few have demonstrated any oxygen
carrier benefit under HMP and SNMP conditions.
We herein report the application of a new preservation solution wherein liver allografts are
oxygenated under dual pressure in subnormothermic conditions with hemoglobin-based oxy-
gen vesicles (HbV) as an oxygen carrier solution. In the present study, an isolated ex vivo
reperfusion model (IRM) simulating reperfusion after transplantation using diluted autolo-
gous blood was evaluated to investigate its utility in MP for DCD livers. This procedure can
reduce the need for animals in transplantation experiments. The aim of this study was to clar-
ify whether or not the use of HbV-containing preservation solution during SNMP improves
the liver graft function of DCD porcine livers in an ex vivo reperfusion model.
Materials and methods
Animals
Domestic female cross-bred Large-Yorkshire, Landrace, and Duroc pigs (approximately 25 kg,
2–3 months of age) were purchased from Daisetsusanrokusya Co., Ltd. Pigs were brought into
the gauge 3–4 days before the experiment and fed 1.2–1.5 kg of food each day. The gauge was
equipped with an automatic water supply system. The floor was made of wire mesh, and excre-
ment was cleaned out twice a day. Starting at 12 h before the experiment, fasting management
was performed in order to ensure the safe administration of general anesthesia. Excision
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procedures were conducted under inhalation anesthesia with isoflurane (Forane VR; Abbot
Japan, Tokyo, Japan). All efforts were made to minimize suffering. After confirming that seda-
tion had been sufficiently achieved, a midline abdominal incision was made, and the animal
was prepared for liver exposing. The pig was injected KCL (10mEq) and leading to cardiac
arrest. After 60 minutes, the liver was rapidly removed. The isolated liver is washed out with
500 ml of Eurocollins solution supplemented with glucose and 3000 units of heparin.
All animal experiments were conducted according to the Guide for the Care and Use
of Laboratory Animals at Asahikawa Medical University. All animal studies and procedures
were approved by Asahikawa Medical University Animal Research Committee (permit no.
14172).
Perfusion preservation machine
The grafts were perfused using an original MP system (Fig 1) [15]. This system consists of the
hepatic artery (HA) and portal vein (PV) perfusion circuits. Each circuit consists of a roller-
type pump (MasterFlex7520-40; Cole-Parmer, Bunker Court Vernon Hills, IL, USA), an elec-
trical flow meter (VN05; Aichi Tokei, Japan for PV; FD-SS02, Keyence, Osaka, Japan for HA),
a ceramic capacitance pressure sensor (KL76; Nagano Keiki, Nagano, Japan), and a custom-
made air trap. An oxygenator (HP0-06 H-C; Senko Medical Instrument, Tokyo, Japan) was
installed in the circuit for the PV and HA. Two optical oxygen sensors (NeoFox; Ocean Optics,
Seattle, FL, USA) were installed to measure the oxygen concentration of the perfusate in the
PV circuit. The temperature of the perfusate was controlled by a heat exchanger and ice-cold
water. The flow rate of the PV was 0.22 mL/min/g (liver) and that of the HA was 0.06 mL/min/
g (liver).
Oxygenation
Oxygen was supplied to the liver grafts during MP (HMP and SNMP) using an oxygenator.
The blending of oxygen and air was controlled with using the air blender of the oxygenator.
The oxygen concentration was maintained to hold the minimum dissolved oxygen concentra-
tion for the calculation of the oxygen consumption at the outlet port.
Fig 1. Machine perfusion system. This system consists of 2 separated perfusion circuits for the hepatic artery (HA)
and portal vein (PV). Each circuit is equipped with a roller pump, a flow meter, a pressure sensor, and an air trap. An
oxygenator was installed in the circuit for the PV and HA to measure the oxygen concentration of the perfusate. The
temperature in the organ chamber was controlled by a heat exchanger and ice-cold water.
https://doi.org/10.1371/journal.pone.0226183.g001
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Experimental design
Grafts were procured with a warm ischemia time (WIT) of 60 min. and were preserved under
CS, HMP or SNMP with HbVs for 4 hours. The perfusate used a modified gluconate Univer-
sity of Wisconsin solution. We used four perfusion conditions in the present study (Fig 2):
1. CS group: liver grafts were preserved with CS for 4 h after 60 min of cardiac arrest. The CS
group is cooled by ice. 5–8 degrees means the temperature of the liver which was cooled
with ice (n = 5).
2. HMP group: liver grafts were perfused with HMP for 4 hours after a WIT of 60 min (n = 5).
3. SNMP group: liver grafts were perfused with SNMP for 4 hours after a WIT of 60 min (n = 5).
4. SNMP+HbV (SNMP with HbV) group: liver grafts were perfused with SNMP; HbVs for 4
hours after a WIT of 60 min (n = 5).
Human-derived hemoglobin vesicles
Sakai et al. demonstrated human-derived hemoglobin vesicles (HbVs) as hemoglobin-derived
oxygen carriers (HBOCs), which encapsulate a purified and concentrated hemoglobin solution
in phospholipid vesicles, like red blood cells (RBCs) [16]. HbVs were prepared from out-of-
date nucleic-acid amplification testing-inspected RBCs provided by the Japanese Red Cross.
The characteristics of HbVs included no blood type, protection against infection due to pas-
teurization and nanofiltration, protection against the toxic effects of molecular hemoglobin,
and stability and biocompatibility [17]. Human-derived HbVs were used as HBOCs. HbVs
were developed 18–20 months after confirming their molecular stability [18].
IRM
Yoshikawa et al. previously described an IRM [19]. The IRM can be useful for the evaluation
of the utility of MP. Briefly, following preservation, all organs were rinsed with 500 mL of cold
Fig 2. Experimental groups. Group 1: The livers were procured under a warm ischemia time of 60 min and preserved
by CS (4–8˚C, n = 5). Group 2: The livers were procured under warm ischemia time of 60 min and preserved by HMP
(6–10˚C, n = 5) with modified gluconate University of Wisconsin solution. Group 3: The livers were procured under
warm ischemia time of 60 min and preserved SNMP with modified gluconate University of Wisconsin solution (22˚C,
n = 5). Group 4: The livers were procured under warm ischemia time of 60 min and preserved SNMP with HbVs
containing preservation solution (22˚C, n = 5).
https://doi.org/10.1371/journal.pone.0226183.g002
Hemoglobin-based oxygen vesicles as a machine perfusion solution for DCD liver donation model
PLOS ONE | https://doi.org/10.1371/journal.pone.0226183 December 11, 2019 4 / 17
Euro-Collins solution for 20 min, and were subsequently exposed at room temperature for 10
min without perfusion to imitate the slow rewarming of the graft during surgical implantation
in vivo. The CS group is perfused with the enough amount perfusate before reperfusion. The
livers were then reperfused with oxygenated diluted autologous blood at 38˚C. The autologous
blood was diluted with 6000 ml of a solution containing saline (40%), low molecular dextran
(20%), calcium (5%), sodium bicarbonate, heparin sodium, and potassium. The hematocrit
was maintained at around 10–12%. The oxygenator was regulated to achieve the following
physiological blood gas values: pO2, approximately 150–200 mmHg; pCO2, approximately 30–
50 mmHg). HA perfusion was set at 80 mmHg and automatically maintained by a roller pump
connected to a pressure sensor placed in the inflow line immediately before the arterial can-
nula. Perfusion of the PV was maintained under a constant flow rate of 0.8 mL/min/g.
The viability assessment during MP
Aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) were taken from the per-
fusate every 30 min and were analyzed to determine the viability of the preserved liver grafts
using agents of standard clinical grade. The blood gas and lactate concentrations in perfusate
were measured using the iStat program (Abbott, Cicago, NJ, USA).
To assess tissue damage, AST and LDH were analyzed. A blood gas analysis was performed
to assess the electrolyte (Na, K, Ca and Cl), lactate and glucose concentrations, and acid/base
physiology (pH, pO2, pCO2, HCO3 and base excess). Lactate was measured as a marker of met-
abolic disorders. The PV and hepatic artery pressure (HAP) was monitored.
Histology
Tissue samples were collected to assess hepatocellular injury before, during and after preserva-
tion, post-reperfusion and at the necropsy performed at the end of the study. All liver samples
were fixed in 10% buffered formalin, embedded in paraffin, sectioned (5 mm) and stained
with hematoxylin and eosin for histological evaluation after preservation and reperfusion.
Microscopic findings
Preparation of osmium macerated samples for observation by a scanning electron microscope
was described previously [20]. In brief, a fixative mixture of 0.5% PFA and 0.5% glutaraldehyde
in 0.1 MPB (pH 7.4) was macerated with liver samples for 30 min at 4˚C. After fixation, the
samples were directly immersed in 1% OsO4 in 0.1 MPB for 6 h at 4˚C. Washed with 0.1 M PB
and samples were cryoprotected with 25% and 50% dimethyl sulfoxide for 30 min. The speci-
men was frozen on a deeply cooled metal plate with liquid nitrogen. The frozen samples were
cracked and transferred into 50% dimethyl sulfoxide for thawing. Samples were washed 3
times with 0.1 MPB and then transferred to 0.1% OsO4 diluted with 0.1 MPB for 90 h at 22˚C
and macerated with osmium. Samples were then immersed for 1 h in 1% OsO4 in 0.1 M PB,
rinsed with 0.1 M PB, and conductively stained with 1% OsO4 in 1% tannic acid and 0.1 M PB.
The samples were then dehydrated in ascending concentrations of ethanol (70%, 80%, 90%,
95%, and 100%) and transferred into 2-Methyl-2-propanol. The samples were frozen and
dried in a freeze-dryer (ES-2030; Hitachi Koki Co., Ltd., Tokyo, Japan). After drying, samples
were placed on an aluminum metal plate and then coated with platinum-palladium in an
ion-sputtering apparatus (E1010; manufactured by Hitachi Koki). The specimens were then
examined by field emission scanning electron microscopy (SEM) (S-4100; Hitachi High
Technologies).
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Statistical analyses
The results are presented as the mean ± standard deviation (SD). T-tests were performed using
the Microsoft Excel 2013 software program (Microsoft, Seattle, WA, USA). After proving the
assumption of normality, differences between groups were tested using a t-test. A repeated
measures analysis of variance was performed using the R software program (version 3.1.2) and
the EZR software program [21]. P values of<0.05 were considered to indicate statistical
significance.
Results
1. HAP and oxygen consumption during perfusion preservation. (Figs 3
and 4)
In the HMP group, the HA pressure after 120 minutes and 240 minutes of perfusion preserva-
tion was 38.4 ± 5.4 mmHg and 34.9 ± 4.4 mmHg, respectively. In the SNMP group, the HA
Fig 3. Hepatic artery pressure during machine preservation HA pressure (HAP) after each perfusion condition
during machine preservation. The HAP was significantly higher than after SNMP+HbV. HMP vs. SNMP with HbV:
※ p<0.05.
https://doi.org/10.1371/journal.pone.0226183.g003
Fig 4. Oxygen consumption during machine preservation. The oxygen consumption in SNMP+HbV was
significantly higher than after HMP. SNMP+HbV vs. HMP: �p<0.05, SNMP vs. HMP: ※ p<0.05.
https://doi.org/10.1371/journal.pone.0226183.g004
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pressure after 120 and 240 minutes of perfusion preservation was 29.4 ± 14.5 mmHg and
37.4 ± 17.1 mmHg, respectively. In the SNMP+HbV group, the HA pressure after 120 and 240
minutes of perfusion preservation was 20.0 ± 5.7 mmHg and 21.7 ± 7.3 mmHg, respectively.
The HAP during perfusion tended to be lower in the HbV + SNMP group compared to the
SNMP group, but there was no significant difference. In the HMP group, the oxygen con-
sumption after 120 and 240 minutes of perfusion preservation was 16.7 ± 4.3mg/min/100g
liver and 12.3 ± 2.9mg/min/100g liver, respectively. In the SNMP group, the oxygen consump-
tion after 120 and 240 minutes of perfusion preservation was 40.7 ± 6.2mg/min/100g liver and
38.6 ± 4.8mg/min/100g liver, respectively. In the SNMP+HbV group, the oxygen consumption
after 120 and 240 minutes of perfusion preservation was 50.3 ± 21.6 mg/min/100g liver and
47.9 ±2.4 ml/min/100g liver, respectively. In the SNMP and SNMP+HbV group, the amount
of oxygen used was much higher than that of the HMP group. Oxygen consumption during
perfusion tended to be higher in the HbV + SNMP group compared to the SNMP group, but
there was no significant difference.
2. AST and LDH in perfusion solution during perfusion preservation (Figs
5 and 6)
In the HMP group, the AST level after 120 and 240 minutes of perfusion preservation was
2020 ± 871 IU/L and 2204 ± 932 IU/L, respectively. In the SNMP group, the AST level after
120 and 240 minutes of perfusion preservation was 2072 ± 691 IU/L and 2149 ± 726 IU/L,
respectively. The AST level of the SNMP group was almost the same as that of the HMP group.
In the SNMP+HbV group, the AST level after 120 and 240 minutes of perfusion preservation
was 1666 ± 1206 IU/L and 1650 ± 1105 IU/L, respectively, which was lower in comparison to
the SNMP and HMP groups. In the HMP group, the LDH level after 120 and 240 minutes of
perfusion preservation was 2830 ± 597 IU/L and 3100 ± 670 IU/L, respectively. In the SNMP
group, the LDH level after 120 and 240 minutes of perfusion preservation was 2524 ± 928 IU/L
and 2704 ± 958 IU/L, respectively. In the SNMP+HbV group, the LDH level after 120 and 240
minutes of perfusion preservation was 1861 ± 1327 IU/L and 2000 ± 1340 IU/L, respectively,
which was lower than that of the SNMP and HMP group.
Fig 5. AST during machine preservation are shown. AST in SNMP with HbVs was lower than HMP and SNMP at
every point after reperfusion.
https://doi.org/10.1371/journal.pone.0226183.g005
Hemoglobin-based oxygen vesicles as a machine perfusion solution for DCD liver donation model
PLOS ONE | https://doi.org/10.1371/journal.pone.0226183 December 11, 2019 7 / 17
3. Changes in PV and HA pressure (Figs 7 and 8)
The change of portal vein pressure was calculated using the following formula: (PV pressure
after 60 minutes of reperfusion)—(PV pressure after 0 minutes of reperfusion) / PV pressure
after 0 minutes of reperfusion. In the CS group, the change of PV pressure was 0.64 ± 0.66
which was the highest among the four groups. In the HMP group, the change of PV pressure
was 0.21 ± 0.75 at 60 minutes of reperfusion. In the SNMP group, the change in PV pressure
was 0.02 ± 0.20. The value in the SNMP with HbV group was -0.06 ± 0.24, which was lower
than that of the CS group. These results showed that the change of PV pressure was lowest in
the SNMP+HbV group. The change in hepatic artery pressure was calculated using the follow-
ing formula: (HA pressure after 60 minutes of reperfusion)—(HA pressure after 0 minutes of
reperfusion) / HA pressure after 0 minutes of reperfusion. In the CS group, the change of HA
pressure was 0.87 ± 0.56 times. In the HMP group, the change of HA pressure was 1.82 ± 0.60,
which was the highest among the four groups and was significantly higher than that of the
HMP and SNMP+HbV groups. In the SNMP group, the change of HA pressure was
1.18 ± 0.59. In the SNMP+HbV group, the change of HAP was 0.46 ± 0.59. These results
showed that the SNMP+HbV group was hemodynamically stable in the isolated reperfusion
phase. But There was no significant difference between HbV + SNMP group and SNMP group
of the changes of HA and PV.
4. AST and LDH in the perfusion solution after reperfusion (Figs 9 and 10)
In the SNMP+HbV group, the AST was 1128 ± 175 IU/L after 120 minutes of reperfusion. The
AST level of this group was the significantly lower in comparison to the other three groups. In
the SNMP group, the AST level was 1408 ± 230 IU/L after 120 minutes of reperfusion, which
was significantly lower than that of the CS group. In the HMP group, the AST level was
1599 ± 417 IU/L after 120 minutes of reperfusion, which was significantly lower than the level
of the CS group. In the CS group, the AST level was 3636 ± 1316 IU/L after 120 minutes of
reperfusion.
In the SNMP+HbV group, the LDH level was 1523 ± 350 IU/L after 120 minutes of reperfu-
sion, which was significantly lower in comparison to the other three groups. In the SNMP
Fig 6. LDH during machine preservation are shown. LDH in SNMP with HbVs was lower than HMP and SNMP at
every point after reperfusion.
https://doi.org/10.1371/journal.pone.0226183.g006
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group, the LDH level was 1604 ± 132 IU/L after 120 minutes of reperfusion, which was signifi-
cantly lower in comparison to the CS group. In the HMP group, LDH was 1810 ± 288 IU/L in
120 minutes of reperfusion, which was significantly lower in comparison to the CS group.
5. pH and lactate after reperfusion (Figs 11 and 12)
The PH after 120 min. of reperfusion were 7.13 ± 0.08, 7.34 ± 0.2, 7.26 ± 0.14, 7.34 ± 0.12 (CS,
HMP, SNMP, SNMP+HbV group). The decrease of PH was higher in the CS group (-0.24
±0.10). The decrease of pH was -0.20 ± 0.08 during 120 minutes of reperfusion in the HMP
group. In the SNMP group, the decrease in pH was -0.19 ± 0.07 after 120 minutes of reperfu-
sion. In the SNMP+HbV group, the decrease of pH was -0.09 ± 0.17 during 120 minutes of
reperfusion, which was the lowest among the four groups. In the SNMP with HbV group, the
decrease of pH was significantly lower than that in the CS and HMP groups. In the CS group,
the increase of lactate was 6.09 ± 0.65 mmol/L at 120 minutes of reperfusion, which was signif-
icantly higher than that in the HMP, SNMP, SNMP with HbV groups. The increase of lactate
was2.61 ± 0.52 mmol/L in HMP and 1.59 ± 0.68 mmol/L in SNMP. On the other hands, in the
SNMP+HbV group, the increase of lactate was 1.55 ± 2.97mmol/L after 120 minutes of
Fig 7. The change in the portal vein pressure. The change in the portal vein pressure was calculated as follows: (PV pressure after 60 minutes of reperfusion)—(PV
pressure after 0 minutes of reperfusion) / PV pressure after 0 minutes of reperfusion. The change of PV pressure (PVP) after each perfusion condition during IRM are
shown. The PVP after CS was higher than HMP and SNMP and SNMP with HbV.
https://doi.org/10.1371/journal.pone.0226183.g007
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reperfusion, which was the lowest among four groups. But There was no significant difference
between HbV + SNMP group and SNMP group of lactate.
6. Histology (Fig 13A–13l))
Fig 13 shows the pathological findings after control (pre preservation), 4hours of preservation
and after 2 hours of reperfusion: a), b) and c) show the CS group at the end of preservation
Fig 8. The change of hepatic artery pressure. The change of hepatic artery pressure was calculated as follows: (HA
pressure after 60 minutes of reperfusion)—(HA pressure after 0 minutes reperfusion) / HA pressure after 0 minutes of
reperfusion. The change of HA pressure (HAP) after each perfusion condition during IRM are shown. The HAP after
HMP was higher than after CS and SNMP and SNMP with HbV. HMP vs. SNMP with HbV: ※ p<0.05, CS vs HMP: �
p<0.05.
https://doi.org/10.1371/journal.pone.0226183.g008
Fig 9. AST level after reperfusion. AST after each perfusion condition during IRM are shown. AST after CS was
significantly higher than HMP, SNMP and SNMP with HbV groups. The AST level of the SNMP with HbV group was
significantly lower in comparison to the other groups: �P<0.05 CS vs HMP, SNMP, SNMP with HbV, ※P<0.05 HMP
vs SNMP with HbV, ✣P<0.05 SNMP vs SNMP with HbV.
https://doi.org/10.1371/journal.pone.0226183.g009
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and reperfusion; d), e) and f) show the HMP group; and g), h) and i) show the SNMP group,
j), k) and l) show SNMP with HbV groups at each time respectively. In the “Control” state,
changes observed in lipid deposits of hepatocytes occurred, but there was no significant change
in the state between the 4 groups. The comparison of the CS, HMP and SNMP groups revealed
that disorder around the central vein damage were suppressed in the HbV+SNMP group.
Edema around the sinusoid was worsened in the CS group. In the HbV+SNMP group, no
HbVs remained at the end of reperfusion.
Fig 10. LDH after reperfusion. LDH after each perfusion condition during IRM are shown. LDH with IRM after CS
was remarkably higher compared with HMP, SNMP, SNMP with HbV groups. The SNMP with HbV group showed a
significantly lower LDH level in comparison to the CS and HMP group. �P<0.05 CS vs HMP, SNMP, SNMP with
HbV, ※P<0.05 HMP vs SNMP with HbV.
https://doi.org/10.1371/journal.pone.0226183.g010
Fig 11. The changes of pH after reperfusion. pH after each perfusion condition during IRM are shown. pH with IRM
after CS was remarkably higher compared with HMP and SNMP with HbV group. CS vs. HMP: � p<0.05, CS vs
SNMP with HbV: ※ p<0.05, CS vs. HMP: ✤ p<0.05.
https://doi.org/10.1371/journal.pone.0226183.g011
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7. SEM (Fig 14A and 14B)
Observation by SEM showed that the form of nucleus and mitochondria in the cytoplasm in
hepatocytes in HMP samples (Fig 14A) higher magnification, strongly swollen mitochondria
as a reflection of their damage under the low oxygenated condition appeared in the
Fig 12. The changes of Lactate after reperfusion. The changes of lactate after CS was significantly higher than HMP
and SNMP and SNMP with HbV groups. The changes of lactate in SNMP with HbV group was significantly lower
than HMP group. CS vs HMP: � p<0.05 CS vs. SNMP: ✤ p<0.05, CS vs SNMP with HbV: ※ p<0.05, HMP vs SNMP
with HbV: ] p<0.05.
https://doi.org/10.1371/journal.pone.0226183.g012
Fig 13. The pathological findings control (pre preservation), after 4hours of preservation and after 2 hours of
reperfusion. a), b) and c) show the CS group at control (pre-preservation), the end of preservation and reperfusion; d),
e) and f) show the HMP group; and g), h) and i) show the SNMP group; j), k) and l) show the SNMP with HbV group
at each time point, respectively. The comparison of the CS, HMP and SNMP groups revealed that disorder around the
central veins and bile duct damage were suppressed in the HbV+SNMP group (arrow). Edema around the sinusoid
was worsened in the CS group (�). In the HbV+SNMP group, no HbVs remained at the end of reperfusion.
https://doi.org/10.1371/journal.pone.0226183.g013
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hepatocytes (Fig 14A). These findings of the organelles in hepatocytes in HMP well correspond
to our findings described previously19. In contrast, the treatment of the SNMP with HbVs
reduced the frequency of appearance of the swollen mitochondria (Fig 14B). High magnified
observation showed that the mitochondria appeared to have a normal function as reflected to
their oxygenated condition with HbVs (Fig 14B). Bars = 1 μm.
Discussion
MP technology has some advantages with regard to DCD liver grafts over CS[6, 12]. For exam-
ple, oxygenated and transportable HMP systems have been shown to reduce the ischemic dam-
age to DCD liver grafts compared with CS [22]. Oxygenated SNMP improves not only the
oxygen uptake but also the adenosine triphosphate content and reduces the lactate levels of the
donor liver [13,14]. Our previous study showed that the oxygen consumption was related to
the graft temperature and associated with the effluent LDH level [23]. However, hypothermic
conditions seem to have limited utility in graft preservation. In addition, cold-induced preser-
vation injury can be caused by reactive oxygen species, leading to mitochondrial injury and
lipid peroxidation [24,14]. MP with oxygenation improves the liver graft viability. Morito et al.
demonstrated that the concentrations of effluent enzymes in SNMP were lower than those in
HMP [23]. These results suggest that oxygen consumption with SNMP reduced the levels of
effluent liver enzymes, thereby ameliorating liver graft injury. Tolboom et al. [25] also reported
Fig 14. (a) Observation by SEM. Observation by SEM showed that the presence of mitochondria in the cytoplasm and reticulated endoplasmic reticulum in
hepatocytes in HMP samples (a) Strongly swollen mitochondria as a reflection of their damage under the low oxygenated condition appeared in the hepatocytes (a). In
contrast, the treatment of the SNMP with HbVs reduced the frequency of appearance of the swollen mitochondria. (b) Observation by SEM. High magnified
observation showed that the mitochondria appeared to have a normal function as reflected to their oxygenated condition with HbV. Bars = 1 μm.
https://doi.org/10.1371/journal.pone.0226183.g014
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that SNMP recovered ischemic damaged rat livers after 1 h WIT. Furukori et al. [26] reported
that SNMP preservation with rewarming maintained the AST and LDH levels in the effluent.
However, these findings had limitations regarding the prediction of general perfusion condi-
tions—in particular the conditions of optimized oxygenated perfusion solutions.
The use of whole-blood ex vivo reperfusion as a pig model for transplantation, was associ-
ated with reduced bile duct injury in DCD grafts in comparison to CS livers [27]. In recent
years, there have been some reports on the use of oxygen carriers for perfusion of the donor
liver. Fontes et al. [28] performed liver transplantation after SNMP in perfusion with Hemo-
pure1 in a pig model. Hemopure1 was reported to improve the oxygen carrying ability
8-fold, and the graft function of the liver that was perfused with Hemopure1 was improved.
That study further showed that, at 21˚C, the perfusate with Hemopure1 kept methemoglobin
levels low, indicating that perfusate with Hemopure1 (hemoglobin = 3.5g/l) provided reliable
oxygen delivery and effective CO2 removal. The additional advantages of the hemoglobin oxy-
gen carrier (HBOC) had unlimited availability, a long storage period, and low risk of disease
dissemination [29, 30].
In the present study, we investigated the influence of SNMP+HbVs oxygen carrier using a
pig isolated liver reperfusion model. We used HbVs produced using human-hemoglobin.
HbVs are a hemoglobin oxygen carrier (HBOC) created using expired RBCs [16], and they
have demonstrated stability, encapsulation efficiency, and biocompatibility [17]. The charac-
teristics of HbVs include no blood type and a long storage life. HbVs are 250 nm in size, which
means they cannot pass through the liver sinusoid.
This study showed that SNMP with oxygen carrier could reduce reperfusion injury in the
DCD donor liver. As shown in Figs 3 and 4, superior preservation conditions were observed in
the SNMP+HbV group. Obara et al; reported that DCD liver grafts require excessive levels of
oxygen [25]. Oxygen was effectively used by the DCD liver grafts in SNMP+HbV, as shown in
Fig 4 and it cannot effectively consume oxygen without an oxygen carrier.
Perfusate with HbVs was found to transport oxygen, even under low Ht conditions. Obara
et al. reported that HA pressure during MP was a reliable marker when using DCD liver grafts
[31]. As shown in Figs 7 and 8, the change of HA pressure and PV pressure in the SNMP
+HbV group were maintained at lower levels than in the HMP and SNMP groups. The con-
centrations of liver enzymes in effluent during preservation were lower than those in the HMP
and SNMP group. As a result, SNMP+HbVs produced preconditioning effects and protected
against liver dysfunction after reperfusion.
The present study also showed that SNMP with HbVs decreased the liver enzyme levels
(AST, LDH) during the reperfusion phase (Figs 9 and 10). Liu Q et al. [32] also reported that
perfusate containing an oxygen carrier was effective in normothermic machine perfusion. We
thought that performing perfusion with SNMP increased the oxygen supply to the liver tissue,
leading to organ protection and contributing to a reduction in the liver enzyme levels.
These results indicate that rapid rewarming following hypothermia at the time of reperfu-
sion, even after 4 h of ischemic time, resulted in preservation-induced damage to the hepato-
cytes of the DCD liver and was associated with severe reperfusion injury. SNMP itself, may be
effective for reducing the rates of reperfusion injury and shear stress. However, SNMP without
any oxygen carrier cannot support metabolic disorders. This study demonstrated that the pH
and lactate level after reperfusion remained maintained low in the SNMP+HbV group, as
shown in Figs 11 and 12.
The storage of energy in mitochondria during preservation is also important. Bochimoto
et al. [20] described the appearance of abnormal vacuoles and invagination of mitochondria in
hepatocytes after 1 h warm ischemia by SEM. In the present study, the hepatocytes preserved
by HMP showed extremely swollen mitochondria, while the SNMP+HbV groups had
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hepatocytes with healthy-looking mitochondria, abundant vacuoles, and membranous struc-
tures sequestrating cellular organelles. As shown in Fig 14, the mitochondria size was recov-
ered and well-maintained in the SNMP+HbV group compared with the HMP group.
Furthermore, the ultrastructure in the hepatocytes of liver grafts changed depending on the
temperature conditions and presence of an oxygen carrier. In this study, the ultrastructural
findings, as shown in Fig 14, revealed that mitochondria size was recovered and well main-
tained in SNMP+HbV group than HMP. Further studies are needed to investigate the mecha-
nisms through which SNMP+HbV perfusion protects the bile duct blood supply and protects
against injury after transplantation. In addition, the protective effect was limited because of the
short period of observation after reperfusion.
Finally, we examine the validity of Hct in this isolated liver reperfusion model. Maione F
et al. [33] review the perfusate composition of the model during reperfusion. Since the perfus-
ate causes ischemia-reperfusion injury, whole blood should be used in reperfusion phase. This
review demonstrated that the Hct in the experiment is about 20%, but there are some that are
higher or lower than that. Yoshikawa et al. [19,34] showed the effectiveness of our evaluation
system. Qiang Liu et al[35].showed the potential role for objective evaluation of reperfusion.
The value of Hct10-12% in our model is a sufficiently acceptable.
This study was associated with some limitations. It was an experimental pig model, and
transplantation was not performed. Furthermore, the results are not sufficient for predicting
the effects of MP and HbVs in a living body, including the immune system effects.
In conclusion, SNMP+HbVs solution based on UW could alleviate hepatocellular reperfu-
sion injury in the donor liver. Oxygenated SNMP+HbVs appears to be promising preservation
method that may improve the functional recovery of the DCD liver during reperfusion.
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